Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thrombin, also known as coagulation factor IIa, is a serine protease enzyme that plays a central role in the blood coagulation cascade. It is responsible for converting soluble fibrinogen into insoluble fibrin strands, which are essential for clot formation and hemostasis. It also activates platelets and other coagulation factors, amplifying the clotting process and is involved in wound healing.
Thrombin inhibitors directly or indirectly block the activity of thrombin, preventing the conversion of fibrinogen to fibrin and subsequent clot formation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thrombin (None).